AbbVie expects IPR&D costs and milestones to affect Q4 results, full-year 2022

news7h01/07/2023

3 Less than a minute

AbbVie headquarters building facade of an American publicly traded biopharmaceutical company

AbbVie expects IPR&D costs and milestones to affect Q4 results, full-year 2022

Source by [author_name]

news7h01/07/2023

3 Less than a minute

news7h

News7h: Update the world's latest breaking news online of the day, breaking news, politics, society today, international mainstream news .Updated news 24/7: Entertainment, Sports...at the World everyday world. Hot news, images, video clips that are updated quickly and reliably